Source comparison
Loading vs Maintenance Phase Protocols
The loading phase serves one purpose: reach steady-state upregulation of cell migration and angiogenic pathways as quickly as possible without exceeding clearance rates. Most research protocols use 2.5–5mg per injection, administered twice weekly, for 4–6 week
This comparison does not assign a generated winner or score.
- The loading phase serves one purpose: reach steady-state upregulation of cell migration and angiogenic pathways as quickly as possible without exceeding clearance rates. Most research protocols use 2.5–5mg per injection, administered twice weekly, for 4–6 weeks. At this frequency, plasma TB-500 concentration remains elevated throughout the week, sustaining VEGF expression and MMP activity.
- A 2014 paper in Cardiovascular Research found that Tβ4 increased MMP-2 activity by 180% in cardiac fibroblasts, but the effect required continuous peptide presence. MMP activity returned to baseline 72 hours after peptide washout. This supports twice-weekly dosing during loading: it prevents the signalling collapse that occurs when TB-500 is cleared faster than new doses are administered.
- Maintenance dosing reduces frequency to once weekly at 2mg. By this point, tissue remodelling cascades are established. New capillaries have formed, fibroblast migration is ongoing, and collagen deposition is structurally organised rather than chaotic. The lower dose sustains these processes without the cost of continuing high-frequency administration indefinitely. Researchers continuing 5mg twice weekly beyond six weeks see diminishing returns.
- Here's the honest answer: if you're dosing TB-500 at 10mg twice weekly because 'more is better,' you're wasting peptide. Receptor saturation occurs well below that threshold. The only scenario where ultra-high dosing might be justified is acute traumatic injury within 48 hours of occurrence, where rapid actin sequestration could theoretically limit scar tissue formation. But even then, clinical evidence supporting doses above 5mg per administration is absent.